Medicine and Pharmacy Reports最新文献

筛选
英文 中文
Implications of type 1 diabetes mellitus in the etiology and clinic of dento-maxillary anomalies - questionnaire-based evaluation of the dentists' opinion.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2822
Maria Simona Dămăşaru, Mariana Păcurar, Mihaela Mariş, Elena Dămăşaru, Marius Mariş, Cornelia Mariana Tilinca
{"title":"Implications of type 1 diabetes mellitus in the etiology and clinic of dento-maxillary anomalies - questionnaire-based evaluation of the dentists' opinion.","authors":"Maria Simona Dămăşaru, Mariana Păcurar, Mihaela Mariş, Elena Dămăşaru, Marius Mariş, Cornelia Mariana Tilinca","doi":"10.15386/mpr-2822","DOIUrl":"10.15386/mpr-2822","url":null,"abstract":"<p><strong>Background and aims: </strong>Type 1 diabetes is one of the most common chronic childhood diseases, which can be diagnosed at any age, with implications on the general development, but also on the craniofacial structure. It is widely speculated that diabetes occurs when inherited genetic characteristics are triggered by environmental factors. Oral pathology is complex and it includes a series of clinical entities: dental caries, periodontal disease, dento-maxillary anomalies, diseases of the oral mucosa, which implies a significant responsibility for the doctor, but also for society. This study aims to highlight the association of dento-maxillary anomalies with juvenile diabetes, starting from its increased prevalence among children and adolescents, the oral manifestations of diabetes mellitus and its influence on the oral microbiome, the increased incidence of periodontal and dental diseases, by means of a questionnaire.</p><p><strong>Method: </strong>A cross-sectional study was carried out on a number of 60 dentists, between 01.01.2023 and 01.03.2024, using a questionnaire with 14 items, which was distributed by e-mail and social networks to dentists of different specialties, from various university. Before completing the questionnaire, the doctors were informed about the purpose of the study and that their answers were anonymous and did not imply any responsibility.</p><p><strong>Results: </strong>Our results indicated awareness of the association between oral health, the presence of dento-maxillary anomalies and the pathology of type 1 diabetes, among dentists of different specialties. The most frequent changes that occur in the oral cavity in the examined patients are represented by carious lesions, reported by 21 examiners (35.00%), of which 18 (39.13%) are female, aged between 25-35 years.Among the reported dentomaxillary anomalies, those of Angle class II were the most frequent - 17 examiners (28.33%), of which 12 (26.09%) are female reported the presence of these anomalies. The presence of Angle class I anomalies was reported by 13 examiners (21.67%) of which 9 (19.57%) are female, while 6 examiners (10.00%) reported the presence of Angle class III anomalies.</p><p><strong>Conclusions: </strong>The evaluation of modern therapeutic methods through questionnaires distributed online represents a feedback of the tested activity and shows that most doctors know the correlations between diabetes and oro-dental diseases and have an obvious healthy attitude. The possible association between oral diseases and the presence of type 1 diabetes was reported by most of the dentists interviewed, however the information on the correlations between oral health and the presence of type 1 diabetes in children was not sufficiently explored by dentists. The dentist must know the clinical particularities of diabetes mellitus and its implications on the oral status, in order to be able to intervene effectively in reducing the oral and systemic compl","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"135-143"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between anxiety, depression, and COVID-19 diagnosis in term pregnancy: a hospital-based Romanian study.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2799
Gabriela Caracostea, Elisabeta Ioana Hirişcău, Andreia Paraschiva Preda, Teodora Turta, Lavinia Argentina Ionescu, Izabela Ramona Lupu, Mihai Surcel, Monica Mihaela Marta, Viorel Lupu, Silviu Matu
{"title":"The relationship between anxiety, depression, and COVID-19 diagnosis in term pregnancy: a hospital-based Romanian study.","authors":"Gabriela Caracostea, Elisabeta Ioana Hirişcău, Andreia Paraschiva Preda, Teodora Turta, Lavinia Argentina Ionescu, Izabela Ramona Lupu, Mihai Surcel, Monica Mihaela Marta, Viorel Lupu, Silviu Matu","doi":"10.15386/mpr-2799","DOIUrl":"10.15386/mpr-2799","url":null,"abstract":"<p><strong>Background and aim: </strong>There are few published data on the mental health problems of women with pregnancy complicated by SARS-CoV-2 infection. Our study aimed to evaluate anxiety and depression related to a COVID-19 diagnosis in women who gave birth in a Romanian tertiary maternity.</p><p><strong>Methods: </strong>A hospital-based cross-sectional study was conducted between September 2020 and October 2021 on 105 women admitted for term delivery; 51 women were diagnosed with SARS-CoV-2 infection just before delivery, and 54 without infection. Participants were assessed during the first 72 hours postpartum (T1) and the following two weeks postpartum (T2). Hospital Anxiety and Depression Scale (HADS) was used for anxiety and depression assessment at T1. The COVID-19 Pandemic Mental Health Questionnaire (CoPaQ) was applied at T2 only in the COVID-positive cases identified at T1.</p><p><strong>Results: </strong>Postnatal anxiety levels were higher in COVID-positive women compared to COVID-negative women (p = .004), but there were no differences in the postnatal depression level between the groups. Psychological manifestations related to the pandemic, such as contamination anxiety, posttraumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD) symptoms, were positively related to HADS anxiety scores, while maintaining social relationships were negatively associated with the scale. The COVID-19 diagnosis was found to be a significant predictor for adverse pregnancy outcomes (APOs), with COVID-positive women having a 4.72-fold higher risk of developing them than those who tested COVID-negative (OR=4.72, 95% CI [2.05; 10.86]). The multivariate analysis using anxiety and depression as dependent variables indicated a significant effect for COVID-19 diagnosis, Wilks' Lambda = 0.940, <i>p</i> = 0.048.</p><p><strong>Conclusion: </strong>Increased levels of anxiety, PTSD, and obsessive-compulsive symptoms were associated with the postpartum period in pregnant women with COVID-19 infection during delivery. Maintaining social interaction proved to be a protective factor against the increased anxiety reported by COVID-19-infected women.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"76-82"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between exocrine pancreatic insufficiency and changes in gut microbiota: a narrative review. 胰腺外分泌功能不全与肠道微生物群变化之间的关系:叙述性综述
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2638
Edina C Şeulean, Dan L Dumitraşcu
{"title":"The association between exocrine pancreatic insufficiency and changes in gut microbiota: a narrative review.","authors":"Edina C Şeulean, Dan L Dumitraşcu","doi":"10.15386/mpr-2638","DOIUrl":"10.15386/mpr-2638","url":null,"abstract":"<p><p>Due to their physical proximity, the healthy pancreas and the gut microbiome are known to interact in a variety of ways. The gut microbiota has been recognized as a potential factor in the development and progression of exocrine pancreatic insufficiency through several mechanisms. Pancreatic diseases like chronic and acute pancreatitis or pancreatic cancer are frequently accompanied by pancreatic exocrine insufficiency which affects the gut microbiota. Firstly, the gut microbes are controlled by antimicrobial pancreatic secretions, while themselves induce the secretion of substances by the pancreas through metabolite production, such as short-chain fatty acids. Secondly, dysbiosis, the alteration in the abundance and diversity of different species, has been observed in patients with pancreatic diseases. Dysbiosis influences carcinogenesis in pancreatic cancer in ways that are either procarcinogenic or anticarcinogenic and finding these connections will have clinical implications. Identifying microbial biomarkers allow for an earlier diagnosis, improved therapy and prognosis in pancreatic cancer. The gut microbiome has a role in the pathogenesis of pancreatitis by either a bacterial translocation or a host immune response mechanism. The disruption of the normal gut barrier is believed to be the primary source of bacteria in acute pancreatitis which leads to infected pancreatic necrosis. In this paper, we review the current data about the association between pancreatic diseases linked to exocrine insufficiency and gut microbiota.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":" ","pages":"5-12"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46784300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing personal and health system barriers to breast cancer early diagnosis practices for women over 20 years old in Cluj-Napoca, Romania.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2694
Mirela Tomic, Oana Blaga
{"title":"Assessing personal and health system barriers to breast cancer early diagnosis practices for women over 20 years old in Cluj-Napoca, Romania.","authors":"Mirela Tomic, Oana Blaga","doi":"10.15386/mpr-2694","DOIUrl":"10.15386/mpr-2694","url":null,"abstract":"<p><strong>Background and aims: </strong>Breast cancer diagnosis is established late in Romania. This led to 3918 potentially avoidable deaths by breast cancer in 2020. Statistics show that women seldom perform monthly breast self-examinations or mammographies. This research aims to identify personal and health system barriers to breast cancer screening, with the purpose of enabling participation in future breast screening programs.</p><p><strong>Methods: </strong>A quantitative cross-sectional, online survey of a convenience sample of 184 women aged 20-65 years old from Cluj-Napoca, Romania was used to evaluate the practice of breast self-exam and mammographies and personal and health system barriers against them.</p><p><strong>Results: </strong>The sample's mean age was 34.73 years (SD=11.31, range 20-65). Women in the sample had a high level of education, most holding a Master's degree (36.4%). The majority declared practicing breast self-examinations from time to time (57.2%) and only (35.5%) did it monthly as per existing guidelines. Personal barriers to breast examination were lack of knowledge (16.3%) and mistrust in self examination (10.3%). Women with higher education engaged in the examination of the breast at least once (X2= (0.047, N = 184), p = 0.003, (CI 95%: 5.515-6.773). Concerning health system barriers, access to information from public health authorities on the availability of mammographies was rated very poor (21.7%). The cost was not a significant barrier to mammographies for 72.8% of the women in the sample.</p><p><strong>Conclusions: </strong>Our study contributes to the limited data on preventive practices for breast cancer in Romania, the EU country that ranks last for breast control among females and where 13% of the 9000+ cases diagnosed annually are stage IV cancers. Based on the reported factors of a successful breast cancer screening program by our sample, we suggest valuable insights to be taken into consideration when organizing a future breast screening program. Both personal and system barriers to breast self-exam and mammographies must be considered in organizing breast cancer screenings. The focus should be on educational initiatives to improve women's knowledge about the process of self-screening and on improving access to information on the availability of free screening and mammograms as part of a well-promoted screening program designed with a simple enrolment process.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"118-124"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of oxidative stress biomarkers for differentiating bacterial and viral infections: a comparative study of glutathione disulfide (GSSG) and reduced glutathione (GSH).
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2821
Zaki Milhelm, Oana Zanoaga, Laura Pop, Andrada Iovita, Paul Chiroi, Antonia Harangus, Cristina Cismaru, Cornelia Braicu, Ioana Berindan-Neagoe
{"title":"Evaluation of oxidative stress biomarkers for differentiating bacterial and viral infections: a comparative study of glutathione disulfide (GSSG) and reduced glutathione (GSH).","authors":"Zaki Milhelm, Oana Zanoaga, Laura Pop, Andrada Iovita, Paul Chiroi, Antonia Harangus, Cristina Cismaru, Cornelia Braicu, Ioana Berindan-Neagoe","doi":"10.15386/mpr-2821","DOIUrl":"10.15386/mpr-2821","url":null,"abstract":"<p><strong>Background and aims: </strong>This study evaluates the potential of oxidative stress biomarkers, specifically glutathione disulfide (GSSG) and reduced glutathione (GSH), for differentiating bacterial and viral infections. Oxidative stress plays a crucial role in the immune response, and glutathione is a key regulator of cellular redox balance. The aim was to assess whether differences in GSH and GSSG levels could be used as diagnostic markers for infection type.</p><p><strong>Methods: </strong>A chemiluminescence-based method evaluated GSH and GSSG as potential biomarkers for distinguishing between bacterial and viral infections. The GSH and GSSG concentrations were analyzed across bacterial, viral, and control groups.</p><p><strong>Results: </strong>Our data revealed significant differences in the GSH/GSSG ratio between the analyzed groups, with bacterial infections showing higher oxidative stress markers compared to viral infections. A combined analysis of GSH and GSSG concentrations, visualized through heatmaps and ROC curves, improved diagnostic accuracy, with clustering patterns distinguishing infection types.</p><p><strong>Conclusions: </strong>These findings suggest that the GSH/GSSG ratio could be used as a biomarker in distinguishing between bacterial and viral infections, offering potential clinical applications for more accurate diagnosis. Further research is required to validate these results in larger cohorts and to explore the underlying mechanisms of oxidative stress in pathogen-specific immune responses.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"46-53"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of CFTR modulatory therapies on liver function and fibrosis indices in cystic fibrosis patients: a retrospective analysis from two Romanian medical centers.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2806
Elena-Simona Moiceanu, Iustina Violeta Stan, Simona Elena Moşescu, Daniel-Corneliu Leucuţa, Maria Iacobescu, Gabriela Viorela Niţescu, Iolanda Cristina Vivisenco, Elena Mădălina Petran, Dan Lucian Dumitraşcu
{"title":"Impact of CFTR modulatory therapies on liver function and fibrosis indices in cystic fibrosis patients: a retrospective analysis from two Romanian medical centers.","authors":"Elena-Simona Moiceanu, Iustina Violeta Stan, Simona Elena Moşescu, Daniel-Corneliu Leucuţa, Maria Iacobescu, Gabriela Viorela Niţescu, Iolanda Cristina Vivisenco, Elena Mădălina Petran, Dan Lucian Dumitraşcu","doi":"10.15386/mpr-2806","DOIUrl":"10.15386/mpr-2806","url":null,"abstract":"<p><strong>Background: </strong>Patients with cystic fibrosis (CF) frequently require modulatory therapies such as Lumacaftor/Ivacaftor (LI) and Elexacaftor/Tezacaftor/Ivacaftor (ETI) to manage their condition. Given the potential hepatic complications associated with CF, it is critical to understand the impact of these therapies on liver function and fibrosis indices. This study aimed to evaluate the changes in liver function markers and fibrosis indices in CF patients undergoing LI and ETI therapies, with a specific focus on the influence of underlying hepatic disease.</p><p><strong>Methods: </strong>In this retrospective analysis, liver function markers and fibrosis indices were assessed in CF patients receiving ETI (n=24), LI (n=4), or LI transitioned to ETI (LI/ETI, n=8). Key liver function markers, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, platelet count, and fibrosis indices (APRI and FIB-4), were measured at baseline and at various time points up to 12 months.</p><p><strong>Results: </strong>In patients receiving LI therapy, ALT and AST levels demonstrated a slight but non-significant decrease over six months, accompanied by significant fluctuations in total bilirubin levels. Among those receiving ETI therapy, ALT and AST levels initially increased but stabilized over time, while total bilirubin levels significantly increased from baseline to 12 months. No significant differences were observed in liver function markers between patients with and without hepatic disease under ETI therapy. Trends in fibrosis indices (APRI and FIB-4) were modest and largely non-significant across both therapies.</p><p><strong>Conclusions: </strong>ETI therapy appears to be safe for CF patients, including those with pre-existing hepatic disease, with no significant deterioration in liver function over a 12-month period. However, the observed fluctuations in bilirubin levels underscore the necessity for ongoing monitoring. Further research is warranted to investigate the long-term hepatic effects of LI and ETI therapies.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"29-35"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient - prosthesis mismatch and its influence on immediate postoperative Von Willebrand factor levels in aortic valve replacement surgery.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2811
Andrei Emanuel Grigorescu, Andrei Anghel, Anamaria Matichescu, Horea Feier
{"title":"Patient - prosthesis mismatch and its influence on immediate postoperative Von Willebrand factor levels in aortic valve replacement surgery.","authors":"Andrei Emanuel Grigorescu, Andrei Anghel, Anamaria Matichescu, Horea Feier","doi":"10.15386/mpr-2811","DOIUrl":"10.15386/mpr-2811","url":null,"abstract":"<p><strong>Background and aims: </strong>Aortic stenosis (AS) often requires surgical aortic valve replacement (SAVR). Patient-prosthesis mismatch (PPM) can lead to suboptimal outcomes. Von Willebrand factor (VWF), crucial for hemostasis, is altered in AS patients. As part of an ongoing study, this research focuses on the impact of PPM on immediate postprocedural VWF levels in SAVR patients, building upon our previous publication on short-term VWF dynamics in SAVR and TAVR.</p><p><strong>Methods: </strong>This prospective study included 31 consecutive patients with severe AS undergoing SAVR. Preoperative and postoperative VWF levels were measured. PPM was assessed based on the indexed effective orifice area of the implanted valve.</p><p><strong>Results: </strong>PPM was observed in 61.29% of patients. Postoperative VWF antigen levels increased significantly (131.37 ± 64.82 IU/dL to 311.01 IU/dL, p<0.01). However, PPM did not significantly influence postoperative VWF antigen levels (285.43 IU/dL vs. 293.30 IU/dL, p=0.88), VWF activity (178.33% vs. 204.76%, p=0.56), or Factor VIII levels (100.38 IU/dL vs. 97.10 IU/dL, p=0.79).</p><p><strong>Conclusions: </strong>While SAVR led to increased VWF levels, PPM did not impact short-term VWF dynamics. This study provides insights into PPM and VWF relationships in SAVR patients, informing valve selection and perioperative management strategies. A future paper will reveal long-term follow-up results, completing this comprehensive investigation of VWF dynamics in aortic valve interventions.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"21-28"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dimitrie Cantemir (1683-1723) and his important contribution to the history of inguinal hernia repair.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2683
Alexandru Eugen Nicolau
{"title":"Dimitrie Cantemir (1683-1723) and his important contribution to the history of inguinal hernia repair.","authors":"Alexandru Eugen Nicolau","doi":"10.15386/mpr-2683","DOIUrl":"10.15386/mpr-2683","url":null,"abstract":"<p><p>In 2023 we celebrated 350 years since the birth, and 300 years since the death of Dimitrie Cantemir (1673-1723), scholar of European prominence, encyclopedic spirit, Prince of Moldavia, first Romanian member of the Berlin Academy of Sciences, and the first in Eastern Europe. Cantemir described for the first time the transperitoneal approach to inguinal hernia repair in his famous work \"The History of the Growth and Decay of the Othman Empire\". The work was written in Latin, revised in 1714-1716 and translated into English by N. Tindal and published in 1734. We briefly present a history of the main existing therapeutic procedures for inguinal hernia repair until the Cantemir's presentation. The description of the procedure is in \"Annotationes\", in the chapter entitled \"Avlonia\", a region from Albania. The Albanians were famous for their skill in repairing inguinal hernias. Cantemir witnessed a hernia repair performed on his secretary in his palace in Istanbul. He gives a detailed description of the procedure, the abdominal incision, reduction of hernial sac content, closing and cauterizing of the hernial orifice with the preservation of the testicle, and the evolution of the patient during the 30 days of follow-up. The postoperative mortality was 1-2%. The surgical technique presented was a progress towards the operations practiced at the time in Europe, mainly cautery and castration. The history of inguinal hernia repair is a mirror of surgical history. The presentation of the transperitoneal approach of the inguinal hernia by the Romanian scholar is of a great importance for the history of surgery and medicine.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"154-159"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the quality of life of schizophrenia patients and their family caregivers in a Romanian sample: the role of clinical, sociocultural, and demographic factors.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2816
Jes Sebastian Denis Völker, Ioana Valentina Micluţia
{"title":"Assessing the quality of life of schizophrenia patients and their family caregivers in a Romanian sample: the role of clinical, sociocultural, and demographic factors.","authors":"Jes Sebastian Denis Völker, Ioana Valentina Micluţia","doi":"10.15386/mpr-2816","DOIUrl":"10.15386/mpr-2816","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Schizophrenia is a chronic mental health disorder significantly impacting the Quality of Life (QOL) of both patients and their family caregivers. In Romania, approximately 193,000 individuals are affected by schizophrenia, with most relying on non-professional family caregivers. These caregivers face substantial psychological, physical, financial, and social challenges, which remain understudied and often overlooked by health policymakers. This research employs a biopsychosocial framework to explore the interconnected clinical, cognitive, and sociocultural factors influencing the QOL of schizophrenia patients and their caregivers.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;This study aims to assess the QOL of schizophrenia patients and their family caregivers in a Romanian sample, focusing on key determinants such as social support, financial stressors, and caregiving burden, to provide insights for interventions and possibly policy development.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This cross-sectional study included 156 individuals: 52 schizophrenia patient-family caregiver pairs (n = 104) and a control group of 52 participants recruited from an occupational health clinic. The control group was matched with the patient-caregiver pairs on demographic characteristics, including age, gender, education, and socioeconomic status. Controls were selected to reflect similar socioeconomic and health-related challenges but excluded individuals with a history of mental health disorders. Schizophrenia diagnoses were established using ICD-10 criteria (F20.0-9). QOL was assessed using the Heinrichs-Carpenter Quality of Life Scale (QLS) exclusively for schizophrenia patients, while the WHOQOL-BREF was administered to all participants to ensure comparability. Additional assessments included the Beck Depression Inventory (BDI) for depressive symptoms, the Montreal Cognitive Assessment (MoCA) for cognitive functioning, the Eppendorf Schizophrenia Inventory (ESI) for caregiver psychopathology, and the Global Assessment of Functioning (GAF) scale to measure functional status.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Caregivers exhibited elevated depressive symptoms, with a mean Beck Depression Inventory (BDI) score of 25 (≥20 indicates moderate depression), highlighting the significant psychological burden associated with caregiving. In contrast, the control group had a mean BDI score of 15, below the clinical threshold. Additionally, caregivers demonstrated reduced cognitive functioning, with a mean Montreal Cognitive Assessment (MoCA) score of 24, compared to 28 in the control group (&lt;26 suggests mild cognitive impairment). These findings underscore the biopsychosocial stressors faced by caregivers.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This study highlights the significant cognitive, psychological, and sociocultural burdens associated with schizophrenia for patients and caregivers, advancing understanding of these challenges in a Romanian context. By emp","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"96-110"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness analysis of the 13-valent pneumococcal conjugate vaccine administered to children under 5 years of age in the Republic of Moldova.
Medicine and Pharmacy Reports Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.15386/mpr-2674
Ana-Mihaela Balanuta, Dina Bujor, Angela Paraschiv, Adela Horodisteanu-Banuh, Ninel Revenco
{"title":"Cost-effectiveness analysis of the 13-valent pneumococcal conjugate vaccine administered to children under 5 years of age in the Republic of Moldova.","authors":"Ana-Mihaela Balanuta, Dina Bujor, Angela Paraschiv, Adela Horodisteanu-Banuh, Ninel Revenco","doi":"10.15386/mpr-2674","DOIUrl":"10.15386/mpr-2674","url":null,"abstract":"<p><strong>Background: </strong>The Moldovan health authorities introduced the 13 valent pneumococcal conjugate vaccine into the national immunization schedule for children in 2013. This study aimed to evaluate the cost-effectiveness of the pneumococcal conjugate vaccine compared to a no-vaccination strategy in children under 5 Years of age in the Republic of Moldova.</p><p><strong>Methods: </strong>We used UNIVAC (version 1.7), a static decision model, to evaluate the health and economic outcomes of vaccination in a single-cohort of children under five years. We modeled vaccine introduction over 10 birth cohorts starting in 2013. We assumed a 2+1 (two doses + booster) schedule and a vaccination price of US$ 16.34 per dose. We used locally-specific data for pneumonia incidence, mortality, treatment, and costs. Model outcomes included pneumonia cases, hospitalizations, deaths, disability-adjusted life years, and costs presented in USD. Cost-effectiveness was reported as Incremental Cost Effectiveness Ratio. The Incremental Cost Effectiveness Ratio was calculated to estimate the additional cost to save an additional life year.</p><p><strong>Results: </strong>From the governmental health sector the Incremental Cost Effectiveness Ratio was $5939 and from society perspective, $7272, respectively. Withal cost per disability-adjusted life years (DALY) averted was US$ 6311. PCV-13 was projected to prevent 2310 hospitalizations due to pneumococcal disease, including 118 deaths. Vaccination could potentially reduce the highest treatment cost from the payer perspective at $ 4 081 412 for the 13 valent pneumococcal conjugate vaccine.</p><p><strong>Conclusion: </strong>This study evidenced that cost per DALY averted is US$ 6311, which is between one and three times Gross Domestic Product (GDP) per capita, these findings extrapolate PCV-13 as a cost-effective intervention. Considering the scenario of Republic of Moldova the PCV program is a cost effective intervention and justifies the introduction of PCV into routine immunization schedule throughout the country in order to reduce morbidity and mortality among the under-five-year-old children.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"98 1","pages":"111-117"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信